Professor John Hammond has been appointed as the next Director of the Roslin Institute and will take up the role in May 2026.

A global study [1] led by Queen’s University Belfast has revealed that tropical amphibians are beginning to resist one of the ...

Newrotex, the Oxford-based clinical-stage biotech developing silk-based medical devices for nerve repair, has taken 1,680 ft2 ...

A Phase I trial led by researchers at The University of Texas MD Anderson Cancer Center has reported that the novel ...

A £750,000 international collaboration has been launched to advance next-generation vaccine development, marking the first ...

The UK maintained a strong position in advanced therapy clinical trials in 2025, with 193 ongoing trials recorded in the Cell and Gene Therapy Catapult’s (CGT Catapult) UK ATMP Clinical Trials ...

Qureight has appointed Dr Steven Bishop as its new Chief Medical Officer, reflecting the company’s continued growth and commercial success in supporting global clinical studies.Previously Chief ...

Biofilms - the microbial ‘cities’ that surround and protect microorganisms - are everywhere on Earth, supporting essential functions in humans, plants, and ecosystems. Now, researchers are ...

For the first time, researchers at the University of Oxford have engineered quantum effects inside proteins, opening the door to a new class of ‘quantum-enabled’ biological technologies.The ...

A 5,500-year-old genome of Treponema pallidum recovered from Colombia has revealed that syphilis-causing bacteria circulated in the Americas millennia before agriculture, undermining the ...

‘Blue sky science’, sometimes known as ‘blue sky research’ or even just ‘basic research’, is the name given to scientific research undertaken in fields where the direct benefits and targets – both ...

Researchers at Baylor College of Medicine have reported a novel blood-based method to detect circulating tumour cells in ...